Menu OUR LEGACY - AND FUTURE - IN AMERICAN MANUFACTURING When you think of a pharmaceutical company, you may picture scientists and researchers in labs creating new or better medications to help tackle diseases. But there’s more. Those scientists and researchers are only one part of the equation. After all, medication is of no use if it does not get to the people who need it. Merck has a dedicated team of people who make these medicines, as well as package and distribute them to the people who need them. These employees, located all over the country, make our break-through inventions a reality. Our manufacturing facilities, suppliers and partners comprise a global manufacturing network that is committed to delivering medicines and vaccines to customers and patients. Merck is part of the fabric of the communities where our 25,000 U.S. employees work and live — in all 50 states across the U.S. We have more manufacturing employees in the U.S. than we have in any other country with full-time employees in highly skilled jobs that pay well and generate growth for the U.S. economy. $3 BILLION Nearly $3 billion in manufacturing assets are currently deployed in the U.S. supporting our global supply of products. $50 BILLION Since 2010, Merck has invested more than $50 billion into R&D, most in the U.S., creating jobs and stimulating local economies. MADE IN U.S. Bulk materials for all of Merck’s FDA-approved vaccines for people in the U.S. are made in the U.S. MADE LOCAL Global manufacturing has its headquarters in New Jersey, and we have grown our West Point, Pennsylvania plant - acquired in the merger with Sharp and Dohme - into the largest in our network. $1 BILLION Over the past decade, Merck has invested more than $1 billion in our manufacturing facilities in the U.S. $1.5 BILLION Last year, Merck paid about $1.5 billion in total U.S. Employer and Employee taxes (including Federal State, local, and unemployment tax) with the Employer-only taxes equaling approximately $250 million. Merck has been manufacturing for more than 125 years. Our current “Manufacturing the Future” strategy focuses on ensuring compliance, becoming a world-class supplier and improving cost-efficiency. Today, as in the past, Merck is dedicated to compliance, safety, and supply chain excellence, as well as “safety first, quality always.” STATE-SPECIFIC INFORMATION: NEW JERSEY +6,000 Employees Home of our global headquarters since 1992. Merck has more than 6,000 employees in New Jersey, many of them researchers. VIRGINIA +700 Employees Merck employs more than 700 employees in Virginia, most at our manufacturing plant in Elkton, in Rockingham County. PENNSYLVANIA +13,000 Employees Merck employs more than 13,000 people in Pennsylvania, with 3,000 in manufacturing and 3,000 in research. Merck’s manufacturing plant in West Point is the largest manufacturing site in our company’s network Merck is the largest private sector employer in Montgomery County and 14th-largest private sector employer in the state NORTH CAROLINA +1,600 Employees Merck employs more than 1,600 employees in North Carolina, most at our manufacturing plants in Durham and Wilson counties. DELAWARE + KANSAS + LOUISIANA + NEBRASKA +800 Employees Merck employs more than 800 people in Animal Health manufacturing plants. Published July 2017 Copyright. © 2009-2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Forward-Looking Statement Privacy Terms of Use Site Map